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Abstract
Background: For the monitoring of International Normalized Ratio (INR) values, venous thromboembolism (VTE)
and atrial fibrillation (AF) patients can visit anticoagulation clinics, laboratories, or physicians for venous puncture.
Point-of-care testing (POCT) made it possible for patients to monitor INR themselves (self-monitoring) and even
self-adjust their medication dosage (self-dosage). Both skills are accepted as forms of self-management. eHealth
applications can improve this self-management, resulting in better clinical outcomes.
Methods: Our study, called PORTALS, aims at identifying the optimal implementation strategy of training to improve
self-management and explore factors that enhance good self-management skills. In addition, the relationship between
the implementation strategy of training, clinical outcomes, and individual characteristics will be investigated. Of the 247
recruited participants, 110 chose to continue with regular care. 137 patients have been randomly divided in subgroups
and compared using a parallel cohort design: one group will be trained and educated by e-learning, and the other
group will receive face-to-face group training.
Discussion: More insight in factors that enhance good self-management will help to improve clinical outcomes and
patient satisfaction on anticoagulation therapy. Our study will provide practical insights and knowledge of eHealth in
daily practice and of the importance of education on the adoption of self-management. We expect the self-management
program including training to help patients to better manage their own INR values and medication use, thereby
increasing health status and diminishing thromboembolic events and hospitalisation.
Trial registration: The Netherlands National Trial Register, number NTR3947.
Keywords: eHealth, Self-management, Self-monitoring, Venous thromboembolism, Atrial fibrillation, Anticoagulant
therapy, e-learning
Background
Venous thromboembolism (VTE) and atrial fibrillation
(AF) are common causes of mortality and morbidity,
and are associated with high medical costs [1]. With the
ageing population and persisting unhealthy lifestyles, the
prevalence of VTE and AF is rising rapidly [2]. Treat-
ment of VTE and AF patients consists of, among other
interventions, anticoagulant therapy (AT) with vitamin
K-antagonists to treat, slow down, or prevent formation of
blood clots [2]. AT demands frequent monitoring of blood
samples to measure its effects. Results are expressed as
International Normalized Ratio or INR values. In 2009
there were over 385.000 patients in the Netherlands who
were treated with anticoagulants, more than half of whom
suffered from AF (211.000 patients) [3]. Between 2005
and 2009 the number of VTE patients in the Netherlands
increased by 13%; the prevalence of AF patients increases
every year, especially amongst males due to the rising sur-
vival rate of myocardial infarcts [4].
For the monitoring of INR, patients have to visit antic-
oagulation clinics, laboratories, or physicians for venous
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puncture. This is one of the major disadvantages of anti-
coagulant therapy with vitamin K antagonists and, to-
gether with frequently occurring unstable anticoagulation,
one of the reasons that other anticoagulants (novel oral
anticoagulants, NOACs) are being developed and often
preferred as an alternative [5]. However, since the alterna-
tives show disadvantages and risks too, improving proce-
dures around vitamin K antagonists attract attention [6].
Point-of-care testing (POCT) is one of these potential
improvements: it generates rapid test results and has
been widely implemented in the last decade. POCT
made it possible for patients to monitor INR values
themselves (self-monitoring) and, as a next step, to even
self-adjust their medication dosage (self-dosage). The
major benefit of this self-management approach is the
increased involvement of patients in their own care
process, thus resulting in improved adherence to AT,
and thereby reduction of complications. Research
showed that self-management in AT patients decreases
the risk of thromboembolic complications and mortality
at a constant frequency of bleeding complications [7].
Several published studies and systematic reviews have
suggested methods of monitoring anticoagulation ther-
apy may be equal to or better than standard monitoring
by a physician. Patients who self-monitor or self-dose
can improve the quality of their oral anticoagulation
therapy [8]. When patients start with self-monitoring or
self-dosage, they receive structured education and train-
ing in self-testing and adjustment of medication dosage.
In addition, eHealth applications are developed in the
form of online web portals to share self-measured INR
values with care professionals. These web portals also
provide programs that support self-adjustment of medica-
tion dosage. Research showed that self-management with
online support results in improved INR values (Time in
Therapeutic Range, TTR, of 10–23%) compared to self-
management without online support (less than 4% im-
provement of TTR) [9, 10]. Moreover, patient satisfaction
is higher when using online remote monitoring of INR
[11]. Based on these results we conclude that eHealth ap-
plications do improve self-management of vitamin K
antagonist anticoagulant therapy, resulting in better
clinical outcomes.
In the last few decades, self-management has become
an important strategy for coping with chronic illnesses.
Adequate self-management requires the individual abil-
ity to deal with symptoms, treatment, and physical and
social consequences of a disease. The basic principle of
self-management is that behavioral change cannot suc-
ceed without patients taking their responsibility [12]. Re-
search on other chronic diseases such as diabetes [13],
COPD [14], and heart failure [15] showed that personal-
ity aspects such as self-efficacy are important factors in
successful self-management. This notion is derived from
the social cognitive theory, which states that behavioral
change is made possible by a personal sense of control.
Self-efficacy has been described as the “belief in one’s
capabilities to organize and execute the course of action
required to produce given attainments”.
As education is the basic approach in development of
self-management skills, we expect that the strategy to
implement the educational support largely affects the in-
dividual level of self-management and thereby clinical
outcomes. However, it is clear that self-management is
not a ‘one-size-fits-all’ intervention. How can self-
management skills then be optimized in a large groups
of individuals, such as patients with AT? Which factors
positively influence the acceptance of self-management?
To answer these questions for patients with AT we de-
signed the PORTALS study.
Our goal is to analyze the effect of the implementation
of e-learning versus a group training on top of a pro-
gram of self-monitoring or self-management. In addition
we will investigate the relationship between the imple-
mentation strategy of training, clinical outcomes, and in-
dividual patient characteristics.
We consider both self-monitoring and self-adjustment
of medication as important self-management skills. In
this study we defined self-management skills as the
usage of the self-management platform; the amount of
login sessions. For this definition, the difference between
self-monitoring and self-dosage is not relevant. Self-
monitoring and self-dosage activities are registered
within the same login session. Therefore, we make no
distinction between patient-self-dosage and patient-self-
testing in this study. All skills are accepted as forms of
self-management.
Methods
In this study, self-management will be offered to patients
of the Saltro Thrombosis Service (outpatient anticoagu-
lation clinic and laboratory), who currently receive usual
care for long-term AT.
Usual care consists of frequent monitoring of blood
samples to measure the effects of vitamin K-antagonists.
These blood samples are taken by classical venipuncture
at primary care locations or at home. Based on the INR,
specialized medical doctors define the acquired dosage
for individual patients and follow puncture; patients re-
ceive the advice and instruction on individual basis.
We used a parallel cohort design to investigate deter-
minants of optimal implementation; we will compare the
different training methods. After inclusion, participants
will be randomly divided in subgroups: one group will
be trained and educated by e-learning (group 1) and the
other group will receive face to face group training
(group 2). Both the e-learning and the group training
consist of at least three components: i) disease-specific
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knowledge of VTE; ii) self-testing skills; iii) use of the
web portal; and iv) self-adjustment of medication. The
fourth module is voluntary. Hence, 2 groups of self-
management patients will be formed. Patients who do
not wish to start with self-management will be invited to
participate in the non-self-management group, a parallel
cohort group describing usual care (group 3). They con-
tinue to receive regular care of high quality. In Fig. 1 the
inclusion of the research groups is summarized.
Due to the nature of this study (implementation re-
search in a real-life care setting) a perfect RCT design is
not feasible: patients cannot be forced to start self-
management. Patients will however be randomized in
group 1 (e-learning) and group 2 (group training). Fur-
thermore, patients unable to dose their medication are
free to continue with only self-monitoring. This study
will be performed using a parallel cohort design. Al-
though bias may occur, the results of this study remain
valuable because in daily practice biases will occur too
when it comes to patients voluntary choosing the type of
care they are willing to receive. Based on our study de-
sign, comparison between e-learning and group training
for self-management (group 1 and 2) and non-self-
management patients (group 3) is applicable considering
specific conditions in the choice of the statistics. Parallel
cohort group 3 provides valuable information about pa-
tients who are unable or unwilling to use online sup-
ported self-management programs.
Power calculation
In thrombosis patients clotting speed is expressed in
INR values. Optimal INR values vary between individual
norms. Therapeutic effects are expressed as the percent-
age of Time the patient is in the Therapeutic INR Range
(TTR). A pilot study of 100 patients of the Saltro
Thrombosis Service Centre shows that the average TTR
is 84% (SD 10). Research shows that TTR improves sig-
nificantly in self-management compared with usual care,
with 5–13% increasing TTR [16]. To prove a relevant ef-
fect of the new implementation strategy of e-learning or
group training (>5%) at a power 80% and α = 0.05, 63 pa-
tients must be included per group. Taking into account
a 15% drop out, 72 (63/0.85) patients are needed per
study group.
Previous studies reported a 21–77% response at inclusion
of study [8, 9, 17]. Even if attrition rate at inclusion
would be only 21%, there are sufficient eligible
patients to reach an adequate sample size: at 21% attrition
rate, 343 patients (72/0.21) must be approached per
group to include sufficient participants in the study.
As this study includes three research groups, a total
of at least 1029 patients is needed to complete the
study. Currently, 8950 patients receive usual care from the
Saltro Thrombosis Service.
Participants
This study focuses on patients of the Saltro Thrombosis
Service who voluntary choose to start with self-
management. The Thrombosis Service states several
inclusion criteria for their patients to start with self-
management. The first criterion is a long-term indication
for anticoagulants as the training period and investments
exceed the regular three to six months of short-term anti-
coagulant prescription. In 2013, 85% of the patient popu-
lation of the Thrombosis Service suffered from long-term
indication for anticoagulants. Secondly, internet access is
mandatory as monitoring of patients by the Saltro Throm-
bosis Service is provided by the web portal. In the
Netherlands 95% of the people have internet access at
home. The average age of patients of the Saltro Throm-
bosis Service is 65 years. In 2013, 61% of Dutch people
over 65 used internet daily and over 75% used it during
the last three months [18]. Of people aged between
55 and 65, 81% used internet on a daily basis [19].
Third, one must have stable INR values: during a
period of at least five days at least two INR values
must be within therapeutic range. Patients who meet
the criteria for self-management will be approached for
participation in the study. Because self-management is
already a regular care process of the Saltro Thrombosis
Service, the group training is also available for people
who are not willing to enter the study. The e-learning
is dedicated for participants of the study as this is a
new implementation method.
Fig. 1 Subdivision within the Saltro Thrombosis Service into three groups; Groups 1 and 2 perform self-management; group 1 was instructed
by e-learning and group 2 by group course. Group 3 receives the usual care, with brief instructions
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Recruitment of patients
Patients of the Saltro Thrombosis Service who receive
regular care will be recruited. In 2013, 8950 patients re-
ceived usual care from the Saltro Thrombosis Service, of
which 85% with long-term indications. A random selec-
tion of 1632 patients was approached for participation in
the study using three methods:
1. First a randomly selected group of 475 patients was
informed by letter. Of these, 233 patient responded
and 59 were willing to participate in the study.
2. Second we approached patients through personal
invitation by nurses of the Saltro Thrombosis
Service who collect blood by venipuncture. All
nurses were trained by the research team to inform
patients well about the study and research goals.
During five months, nurses actively informed 692
patients about self-management. Of those, 139
patients were interested to participate in the study.
In addition, 234 were interested in self-management
too, but not in participation in the study.
3. Third we recruited patients by telephone. Two
trained research assistants called patients at home
to inform them about the possibilities of self-
management and about the study. By telephone 465
patients were approached, of which 111 were willing
to participate in the study. In addition, 52 patients
signed up for self-management but were not willing
to participate in the study.
Participants were only included in the study after writ-
ten informed consent was received. Because not all pa-
tients signed an informed consent, 247 participants were
finally included. Of these, 110 continued to receive regular
care and 137 patients were randomly divided in group 1
and 2 using a computer program. In group 1 (e-learning)
63 patients were included and in group 2 (group training)
74 patients were included. In Fig. 2 recruitment is
summarized.
Patients who are willing to participate will receive re-
wards: a € 25,- gift card after completing the first set of
questionnaires and a € 50,- gift card after completing the
last set of questionnaires after 18 months.
Responder analysis
The total population of the Saltro Thrombosis Service on
January 1st, 2014 was 10.209 patients of which 8.939 pa-
tients received regular care (eligible patients) and 1.271
self-management (894 self-monitoring and 377 self-
dosage). 53% were men and 47% women. The mean age
was 73 years (SD 14). In the study population 247 patients
were included of which 72.9% were men and 27.1%
women. The median age was 66.9 (IQR 59.5–72.7) years
in the total group; 65 years in group 1 and 65.8 years in
group 2, and 69.6 years in group 3.
Analysis showed a significant difference in median age
between the groups. Younger men participated in the
PORTALS trial compared to patients who declined par-
ticipation. The average INR of the participants did not
significantly differ from the eligible population at the
start of the study. In Fig. 3 the characteristics of the pa-
tients are summarized.
Among patients who were recruited by letter we asked
non-participants to inform us about their reasons. 35 pa-
tients filled in the non-responders form 12 patients did
not want to start self-management because they had no
computer or internet access, 7 patients were satisfied with
regular care and wanted to continue it, 6 patients felt they
were too old, 10 patients had other reasons such as painful
fingers (1), physical inabilities (2), training is too much ef-
fort (2), insecurity (2) or unknown reasons (3).
Allocation procedure
Participants were randomly selected for e-learning
(group 1) or group course (group 2) during the registra-
tion procedure for the training by a computerized pro-
gram. Participation in group 3 was not randomized but
free choice for patients.
Fig. 2 Schematic summary of recruitment; A schematic summary of the number of eligible patients, how many of them were approached, with
what method they were approached, how many responded, how many are participating, and in which group
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In Fig. 2 the total amount of included patients is
summarized.
Intervention
This study investigates the effect of different implementa-
tion strategies on adequate training for self-management
skills in patients with AT expressed in TTR, as well as po-
tential determinants of the effect. We compare group
training versus e-learning. Patients who follow e-learning
have to pass at least three modules. The first module con-
tains general education about anticoagulation including
test questions. Patients can only successfully pass this first
module after all questions are answered correctly. They
then receive a written confirmation. With this confirmation
patients can pick up a self-testing device at one of the
Saltro Thrombosis Service locations. Furthermore, patients
get access to the second module that teaches them to use
the self-testing device. After one or two weeks patients have
an appointment with a nurse of the Thrombosis Service
Centre to show their self-testing skills. If the skills are suffi-
cient, the nurse explains the patients how to use the online
web portal. The following three months a training period is
applicable, during which patients measure their INR weekly
and inform the Thrombosis Service using the web portal.
After three months, patients have another control appoint-
ment to check their self-testing skills technique and
adequate use of the web portal. If patients are able to pro-
vide reliable INR values by self-measurement and if they
adequately use the web portal to inform the Thrombosis
Service about testing results and relevant medical informa-
tion, the self-monitoring training is ended. From that
moment on, patients have control appointments with the
nurse every six months. In addition, patients are offered to
continue with training in self-adjustment of medication
dosage. This training is only available in a group course.
The group training consists of two meetings. During the
first meeting patients are trained to use the device to
measure their own INR and they are trained to use the
web portal. Patients practice at home for three weeks. At
the second meeting the capillary technique of patients is
checked by nurses of the Thrombosis Service. In addition,
patients receive general education about anticoagulation.
The following three months a training period is applicable
during which patients measure their INR weekly and in-
form the Thrombosis Service using the web portal. After
three months patients have a control appointment with
the nurse to check their capillary technique and to discuss
the training period. If patients are able to provide reliable
INR values by self-measurement and if they adequately
use the web portal to inform the Thrombosis Service
about testing results and relevant medical information,
the self-management training is ended. From that mo-
ment on, patients have control appointments with the
nurse every six months. In addition, patients are offered to
continue with training in self-adjustment of medication
dosage. This training is only available in a group course.
The regular care group receives traditional thrombosis
care, which means a basic instruction by nurses of the
Saltro Thrombosis Service in their own home. Patients are
explained what locations they can go to for venous punc-
ture. Based on analyses of the blood samples (INR values)
professional thrombosis doctors give written instructions
about medication dosage and lifestyle to the VTE patients.
This also includes indication for follow-up puncture.
All training schedules are summarized in Fig. 4.
Data collection
The data collection consists of questionnaires to meas-
ure the determinants and secondary outcomes, that pa-
tients of group 1 and 2 receive by e-mail. Patients in
research group 3 (who do not work with the web portal)
receive the same questionnaires either by e-mail or post.
In case of non-response we will send two reminders by
mail or email and will approach the patients once by
telephone. In Fig. 5 planning of measurements is sum-
marized. There are four measurements in this study
during a period of 18 months. INR values and thrombo-
embolic events are monitored and registered daily by
professionals of the Saltro Thrombosis Service. In
addition health care use, the number of self-tests and
use of the portal are continuously registered in the web
portal. Data collection is summarized in Fig. 5.
Outcome parameters
At first we compare clinical outcomes (TTR) and com-
plications between three groups; second we compare
Fig. 3 Characteristics of eligible patients versus included patients; The average age, percentage of males, and average INR of eligible patients versus
included patients is shown
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TTR, complications and self-management skills of two
different implementation methods in group 1 and 2. Sec-
ond, the relationship between self-management skills,
clinical outcomes, and individual characteristics will be
investigated.
Primary outcome
Health status is the primary outcome, expressed by TTR
and severe complications (bleedings and thromboembolic
events). TTR is computed as INR values within therapeutic
range based on individual targets, calculated with the
Rosendaal method [20]. INR values will be measured using
a whole blood PT/INR monitor (CoaguChek, Boehringer
Mannheim, Germany). Bleedings and thromboembolic
events will be registered in patient files by professionals of
the Saltro Thrombosis Service during the total study
period of 18 months. Events can be reported by general
practitioners and hospital professionals by e-mail or
telephone, or by patients themselves using the online por-
tal, e-mail, or telephone.
In this study, adequate self-management skills are de-
fined as a) the ability to correctly measure one’s own
Fig. 4 Time course for group 1, 2 and 3; The three groups and the time courses of their trainings, blood testing procedures, and instructions
Fig. 5 Measurements over time; A schematic overview of the different types of measurements on T1 = 0, T2 = 6, T3 = 12, and T4 = 18 months
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INR; b) the ability to use the online web portal to report
all measured INR values; c) the ability to use the online
web portal to report all relevant medical conditions and
d) the ability to correctly calculate dosage schedules.
The latter being only applicable if patients voluntary
choose to self-adjust their own medication intake. Correct
self-testing of INR will be judged by thrombosis nurses
during yearly control visits. We registered the usage of the
self-management platform, including sharing of informa-
tion and calculation of medication dosage; the amount of
login sessions will be used as a measure for self-
management skills. The usage counts will be analyzed.
Determinants
We expect that the relationship between the level of
self-management skills and clinical outcomes is influ-
enced by socio-demographic, (psycho) social characteris-
tics, and self-efficacy.
Self-efficacy is measured using the Generalized Self-
Efficacy Scale (GSES), which will be displayed at base-
line. This 10-item questionnaire was designed in 1981 by
Jerusalem en Schwarzer [21]. The items are scored by a
four-point scale on which a higher score reflects higher
self-efficacy. Research in 28 countries showed that Cron-
bach’s alpha varies between .76 and .90, of which mostly
above .80 [22].
Socio-demographic characteristics will be assessed by a
purpose-designed questionnaire (online). As use of the
web portal is part of the self-management program and
as decreased access to internet and low general health
outcomes have been associated with lower socioeco-
nomic status, minority racial/ethnic groups, older age,
and poorer health we will also include the following
characteristics in our questionnaires: age, socioeconomic
status, marital status, and general use of online and
digital products and services.
Secondary outcomes
Quality of life (QoL) is assessed using the EuroQol-5D
(EQ-5D). This questionnaire contains 5 items with a 3-
point Likert scale. A higher score reflects a higher quality
of life. The EQ-5D comprises 5 levels: mobility, self-care,
daily activity, pain/discomfort, and anxiety/depression. Re-
search showed that the EQ-5D is a reliable and valid ques-
tionnaire [23]. The EQ-5D can be used to compute
QALY’s, which are necessary to evaluate cost-effectiveness.
Direct costs of both intervention methods will be in-
cluded in this study. Intervention costs include develop-
ment costs of e-learning and costs of group courses.
Development costs are provided retrospectively by the
owner of the portal. Implementation costs are adminis-
tered by the research group, and mainly consist of
personnel costs and practice materials.
Health care use of the Saltro Thrombosis Service is
constantly registered in this study the health care use of
the Saltro Thrombosis Service is constantly registered.
Data analyses
1. Baseline characteristics between the 3 groups will be
explored using Chi-square tests and Kruskal-Wallis
tests.
2. To investigate the effect of different implementation
methods of training versus the parallel cohort group,
TTR and complications between groups will be
analyzed using multilevel linear regression modelling
(mixed models). First, outcomes will be compared
between the three groups. A second analysis will be
used to compare the difference in effect between
e-learning and group training (group 1 vs group 2) on
TTR, complications and usage using mixed models.
Analyses will be adjusted for age and gender.
3. To examine the impact of GSES and education on
the effect of different implementation methods,
those variables will be included in the mixed models.
Ethical principles
Increasing costs and deficit of health care professionals
stress the urge for efficient health care processes. Benefits
of online supported self-management regarding clinical ef-
fects have been repeatedly demonstrated, but extensive
integration in clinical practice stays behind. This study
aims to explore implementation methods for optimal inte-
gration of online supported self-management in primary
care. Optimal integration stimulates patients in self-
management and improves efficiency and accuracy ad-
ministration and communication. We expect patients to
improve their health status while decreasing health care
use. On the other hand, self-management will not be of-
fered to patients who are unable to use internet. They will
however not be in disadvantage by receiving usual care.
All over, this study will be conducted according to the
principles of the Declaration of Helsinki (version 59, 2008)
and in accordance with the Medical Research Involving
Human Subjects Act (WMO).
Trial status
PORTALS is an ongoing trial.
Discussion
Adequate self-management requires the individual abil-
ity to deal with symptoms, treatment, and physical and
social consequences of a disease. The basic principle is
that behavioral change cannot succeed without patients
taking their responsibility [24]. Education is an import-
ant factor for the enhancement of self-management
skills; research showed that patients who understand
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more about their disease, health, and lifestyle have better
experiences and health outcomes and often use less
health care resources. The effect is even bigger when
these patients are empowered to and responsible for
managing their health and disease [25].
In this study we aim to empower patients with AT by
providing self-management including a web portal and
education. We expect this self-management program to
help patients to better manage their own INR values and
medication use, thereby increasing health status and
diminishing thromboembolic events and hospitalisation.
Health status (INR and TTR) is the main outcome. We in-
vestigate the optimal implementation strategy of training
of self-management and the relationship with personality
and characteristics to provide practical insights in deter-
minants of successful implementation of patient self-
management portals in real-life thrombosis care settings.
By analyzing the non-participation reasons (35 patients),
we can conclude that the possession of a computer, age
and satisfaction with usual care are the most important rea-
sons not to start with this study. These aspects can create a
bias in the individual ability of the whole self-management
group of patients how to deal with their disease.
This PORTALS study has several strengths. The self-
management in combination with a web portal and dif-
ferent forms of education are integrated in real life care
settings and will therefore provide practical insights and
knowledge of eHealth in daily practice. We expect to
learn what type of education can be a significant factor
in the adoption of self-management. Furthermore, this
study adds Dutch evidence to the existing body of know-
ledge which is important because local political and
financial factors have a major impact on successful inte-
gration in daily practice [26]. This study also has several
limitations: from a technical perspective the develop-
ment of the web portal is a difficult task due to lack of
broad experience in the field. The content of the web
portal will affect our outcomes, but is beyond the scope
and influence of our study. From a human perspective,
effects through self-management imply behavioural
changes. Behavioural changes require time, whereas the
study period is limited to 18 months.
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